MGR
★    

India,
2007-11-26 13:39
(6786 d 02:24 ago)

Posting: # 1332
Views: 7,690
 

 Tablet vs Capsule [Design Issues]

Dear all,

I had a small doubt regarding the study design. Can we compare two products T and R (both are immediate release products only) but 'T' is a tablet and 'R' is an capsule formulation. Can we do a BE study for this to FDA? Can FDA accept this or not? Thanks in advance.

Regards,
MGR
H_Rotter
★    

Germany,
2007-11-26 15:42
(6786 d 00:21 ago)

@ MGR
Posting: # 1333
Views: 6,299
 

 Tablet vs Capsule

Dear MGR!

❝ ... Can we compare two products T and R (both are immediate release products only) but 'T' is a tablet and 'R' is an capsule formulation.


Fine according to European regulations - pharmaceutical equivalents or pharmaceutial alternatives may be compared.

❝ Can we do a BE study for this to FDA? Can FDA accept this or not?


In the USA only pharmaceutical equivalents (the reference listed drug - RLD) may be used.

Best regards,
Hermann
Noha Abdeljawad
☆    

Cairo, Egypt,
2014-08-25 13:20
(4322 d 03:43 ago)

@ H_Rotter
Posting: # 13426
Views: 5,177
 

 Tablet vs Capsule

Dear H_Rotter

❝ Fine according to European regulations - pharmaceutical equivalents or pharmaceutical alternatives may be compared.


Could you please refer me to the part of the guideline that says that.

Thanks

Best Regards
Noha Abdeljawad
Ohlbe
★★★

France,
2014-08-25 13:57
(4322 d 03:06 ago)

@ Noha Abdeljawad
Posting: # 13427
Views: 5,164
 

 Tablet vs Capsule

Dear Noha,

❝ Could you please refer me to the part of the guideline that says that.


Have a look not at the BE guideline, but at Directive 2001/83/EC, Article 10, paragraph 2(b), in the definition of a generic medicinal product:

‘generic medicinal product’ shall mean a medicinal product which has the same qualitative and quantitative composition in active substances and the same pharmaceutical form as the reference medicinal product, and whose bioequivalence with the reference medicinal product has been demonstrated by appropriate bioavailability studies. [...] The various immediate-release oral pharmaceutical forms shall be considered to be one and the same pharmaceutical form.

Regards
Ohlbe
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
137 visitors (0 registered, 137 guests [including 12 identified bots]).
Forum time: 17:03 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5